NCT02100683 - Nit-Occlud PDA Post-Approval Study | Biotech Hunter

Enrollment

184

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

November 20, 2019

Study Completion Date

August 10, 2022

Conditions

Patent Ductus Arteriosus (PDA)

Interventions

DEVICE

PDA Coil

The Nit-Occlud PDA is a permanently implanted prosthesis indicated for percutaneous, transcatheter closure of small to moderate size patent ductus arteriosus with a minimum angiographic diameter \< 4 mm.

Trial Locations (11)

19104

Children's Hospital of Philadelphia, Philadelphia

43205

Nationwide Children's Hospital, Columbus

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

48201

Children's Hospital of Michigan, Detroit

55454

University of Minnesota Masonic Children's Hospital, Minneapolis

60453

Advocate Christ Medical Center, Oak Lawn

75235

Children's Medical Center of Dallas, Dallas

90027

Kaiser Permanente, Los Angeles

92354

Loma Linda University Medical Center, Loma Linda

93636

Children's Hospital of Central California, Madera

98105

Seattle Children's Hospital, Seattle